Value Hunters: Look To Coherus Biosciences Inc (CHRS)
Currently, there are 115.21M common shares owned by the public and among those 110.99M shares have been available to trade. The company’s stock has a 5-day price change of -15.91% and 39.78% over the past three months. CHRS shares are trading -19.57% year to date (YTD), with the 12-month market performance down to -53.16% lower. […]
Coherus Biosciences Inc (NASDAQ: CHRS) Not A Good Play Anymore?
Coherus Biosciences Inc (CHRS) concluded trading on Thursday at a closing price of $1.28, with 4.21 million shares of worth about $5.39 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -22.89% during that period and on January 23, 2025 the price saw a […]
Do Coherus Biosciences Inc (NASDAQ: CHRS) Fit In A Value Investing Philosophy?
Currently, there are 111.36M common shares owned by the public and among those 106.20M shares have been available to trade. Insiders at the company have transacted a total of 3 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, […]
Is Coherus Biosciences Inc (NASDAQ: CHRS) Proving The Doubters Wrong?
Coherus Biosciences Inc (CHRS) concluded trading on Thursday at a closing price of $2.09, with 3.42 million shares of worth about $7.16 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -51.84% during that period and on Thursday, February 01 price saw a loss […]
Gains May Be On The Menu For Coherus Biosciences Inc (NASDAQ: CHRS)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Coherus Biosciences Inc (NASDAQ:CHRS). The institutional investor has increased its shareholding in the Healthcare company by 4.89% to 9.55 million shares with purchase of 0.44 million shares. This fresh investment now brings its stake to 8.58% valued currently at $31.8 million. In addition, […]
Growing Through Challenges? – Coherus Biosciences Inc (CHRS)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Coherus Biosciences Inc (NASDAQ:CHRS). The institutional investor has increased its shareholding in the Healthcare company by 4.89% to 9.55 million shares with purchase of 0.44 million shares. This fresh investment now brings its stake to 8.58% valued currently at $20.34 million. In addition, […]
Do Coherus Biosciences Inc (NASDAQ: CHRS) Fit In A Value Investing Philosophy?
The Vanguard Group, Inc. recently announced the acquisition of new stake in Coherus Biosciences Inc (NASDAQ:CHRS). The institutional investor has increased its shareholding in the Healthcare company by 4.89% to 9.55 million shares with purchase of 0.44 million shares. This fresh investment now brings its stake to 8.58% valued currently at $20.34 million. In addition, […]
Coherus Biosciences Inc (NASDAQ: CHRS) Hogging The Spotlight Today
With over 8.24 million Coherus Biosciences Inc (CHRS) shares trading Tuesday and a closing price of $2.18 on the day, the dollar volume was approximately $17.97 million. The shares have shown a negative half year performance of -43.23% and its price on 12/26/23 gained nearly 7.92%. Currently, there are 111.36M common shares owned by the […]
There Is Clear Momentum For Coherus Biosciences Inc (NASDAQ: CHRS)
The Vanguard Group, Inc. has recently announced that it has increased stake in Coherus Biosciences Inc (NASDAQ:CHRS) by 4.89%. After grabbing 9.55 million shares, the institutional investor is now in possession of 0.44 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 8.58% having worth around $20.34 million. […]
